Risk of Symptomatic Intracerebral Hemorrhage in Patients Treated with Intra-Arterial Thrombolysis

BACKGROUND: In intra-arterial (IA) thrombolysis trials, higher rates of symptomatic intracerebral haemorrhage (sICH) were found than in trials with intravenous (IV) recombinant tissue plasminogen activator (tPA); this observation could have been due to the inclusion of more severely affected patient...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Singer, O.C., Berkefeld, J., Lorenz, M.W., Fiehler, J., Albers, G.W., Lansberg, M.G., Kastrup, A., Rovira, A., Liebeskind, D.S., Gass, A., Rosso, A., Derex, L., Kim, J.S., Neumann-Haefelin, T.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: S. Karger AG 2009
Konular:
Original Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2715450/
https://ncbi.nlm.nih.gov/pubmed/19218803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000202427
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller